0002109738-26-000003.txt : 20261007 0002109738-26-000003.hdr.sgml : 20261007 20261007121538 ACCESSION NUMBER: 0002109738-26-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261007 DATE AS OF CHANGE: 20261007 EFFECTIVENESS DATE: 20261007 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CytoTerra Inc. CENTRAL INDEX KEY: 0002109738 ORGANIZATION NAME: EIN: 394679403 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-600254 FILM NUMBER: 261446195 BUSINESS ADDRESS: STREET 1: 3005 1ST AVE, SUITE 205 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 410-382-8042 MAIL ADDRESS: STREET 1: 3005 1ST AVE, SUITE 205 CITY: SEATTLE STATE: WA ZIP: 98121 D 1 primary_doc.xml X0708 D LIVE 0002109738 CytoTerra Inc. 3005 1ST AVE, SUITE 205 SEATTLE WA WASHINGTON 98121 410-382-8042 DELAWARE None None Corporation true 2025 Stephen Eacker 3005 1st Ave, Suite 205 Seattle WA WASHINGTON 98121 Executive Officer Director Promoter Jesse Salk 3005 1st Ave, Suite 205 Seattle WA WASHINGTON 98121 Director Kenneth Horenstein 3005 1st Ave, Suite 205 Seattle WA WASHINGTON 98121 Director Sean MacLeod 3005 1st Ave, Suite 205 Seattle WA WASHINGTON 98121 Executive Officer Other Technology Decline to Disclose 06b false 2026-09-25 false true true false 0 1000000 300000 700000 false 2 0 0 0 false CytoTerra Inc. Stephen Eacker Stephen Eacker Chief Executive Officer 2026-10-07